The subpopulation of breast CSCs is characterized by phenotype CD44+/CD24low/- [9, 10], by their tumor-initiation capability in immune-compromised mice [11] and by an in vitro ability to form mammospheres [12, 13]. The gene discussed is CD44; the disease is neoplasm.